NEUROBIOLOGY OF AGING | 卷:94 |
Influence of apolipoprotein-E genotype on brain amyloid load and longitudinal trajectories | |
Article | |
Lopresti, Brian J.1  Campbell, Elizabeth M.1  Yu, Zheming1  Anderson, Stewart J.2  Cohen, Ann D.3  Minhas, Davneet S.1  Snitz, Beth E.4  Royse, Sarah K.1  Becker, Carl R.1  Aizenstein, Howard J.3  Mathis, Chester A.1  Lopez, Oscar L.4  Klunk, William E.3  Tudorascu, Dana L.2,3  | |
[1] Univ Pittsburgh, Sch Med, Dept Radiol, Pittsburgh, PA USA | |
[2] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA | |
[3] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA | |
[4] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA | |
关键词: Alzheimer's disease; Apolipoprotein-E; Positron emission tomography (PET); Amyloid; Genetics; | |
DOI : 10.1016/j.neurobiolaging.2020.05.012 | |
来源: Elsevier | |
【 摘 要 】
To characterize the influence of apolipoprotein-E (APOE) genotype on cerebral A beta load and longitudinal A beta trajectories, [C-11]Pittsburgh compound-B (PiB) positron emission tomography (PET) imaging was used to assess amyloid load in a clinically heterogeneous cohort of 428 elderly participants with known APOE genotype. Serial [C-11 epsilon]PiB data and a repeated measures model were used to model amyloid trajectories in a subset of 235 participants classified on the basis of APOE genotype. We found that APOE-epsilon 4 was associated with increased A beta burden and an earlier age of onset of A beta positivity, whereas APOE-epsilon 2 appeared to have modest protective effects against A beta. APOE class did not predict rates of A beta accumulation. The present study suggests that APOE modifies Alzheimer's disease risk through a direct influence on amyloidogenic processes, which manifests as an earlier age of onset of A beta positivity, although it is likely that other genetic, environmental, and lifestyle factors are important. (C) 2020 Elsevier Inc. All rights reserved.
【 授权许可】
Free
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
10_1016_j_neurobiolaging_2020_05_012.pdf | 1141KB | download |